Androgen receptor mediated growth control of breast cancer and endometrial cancer modulated by antiandrogen- and androgen-like steroids

Journal of Steroid Biochemistry and Molecular Biology

Volumn 56, Issue 1-6, 1996, Pages 113-117

  Hackenberg, Reinhard ^a   Schulz, Klaus Dieter ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; ANDROGEN RECEPTOR; ANDROSTENEDIOL; ESTROGEN RECEPTOR; MEDROXYPROGESTERONE ACETATE; PROGESTERONE RECEPTOR; UNCLASSIFIED DRUG;

BREAST CANCER; CELL LINE; CONFERENCE PAPER; CONTROLLED STUDY; CYST FLUID; ENDOMETRIUM CANCER; FEMALE; HISTOCHEMISTRY; HUMAN;

EID: 0029872401     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/0960-0760(95)00228-6     Document Type: Conference Paper

References (56)

1. Wagner R. K., Görlich L. and Jungblut P. W.: Dihydrotestosterone receptors in human mammary cancer. Acta Endocr. 65 (1973) 173-181.
2. Maass H., Engel B., Nowakowski H., Stolzenbach G. and Trams G.: Estrogen receptors in human breast cancer and clinical correlations. In Estrogen Receptors in Human Breast Cancer (Edited by W. L. McGuire, P. P. Carbone and E. P. Vollmer). Raven Press, New York (1975) pp. 175-183.
3. Lippman M. E. and Huff K. K.: A demonstration of androgen and estrogen receptors in human breast cancer using a new protamine sulfate assay. Cancer 38 (1976) 868-874.
4. Barnes D. M., Ribeird G. G. and Skinner L. G.: Two methods for measurement of oestradiol-17β and progesterone receptors in human breast cancer cases and correlation with response to treatment. Eur. J. Cancer 13 (1977) 1133-1138.
5. McGuire W. L., Horwitz K. B., Pearson O. H. and Segaloff A.: Current status of estrogen and progesterone receptors in breast cancer. Cancer 39 (1977) 2934-2947.
6. Allegra J. C., Lippman M. E., Thompson E. B., Simon R., Barlock A., Green L., Huff K. K., Do H. M. T., Aitken S. and Warren R.: Steroid hormone receptors in human breast cancer. Proc. Am. Assoc. Cancer Res. 19 (1978) 336-339.
7. Bryan R. M., Mercer R. J., Bennet R. C., Rennie G. C., Lie T. H. and Morgan F. J.: Androgen receptors in breast cancer. Cancer 54 (1984) 2436-2440.
8. Lea O. A., Kvinnsland S. and Thorsen T.: Improved measurement of androgen receptors in human breast cancer. Cancer Res. 49 (1989) 7162-7167.
9. Allegra J. C., Lippman M. E., Thompson E. B., Simon R., Barlock A., Green L., Huff K. K., Do H. M. T. and Aitken S. C.: Distribution, frequency, and quantitative analysis of estrogen, progesterone, androgen and glucocorticoid receptors in human breast cancer. Cancer Res. 39 (1979) 1447-1454.
10. Miller W. R., Telford J., Dixon J. M. and Hawkins R. A.: Androgen receptor activity in human breast cancer and its relationship with oestrogen and progesterone receptor activity. Eur. J. Cancer Clin. Oncol. 21 (1985) 539-542.
11. Würz H., Schulz K.-D., Citoler P. and Kaiser R.: Verteilung von Östrogen-, Gestagen-, Androgen- und Kortikosteroidrezeptoren in Mammakarzinomen. In Steroidhormonrezeptoren im Karzinomgewebe (Edited by W. Jonat and H. Maass). Enke, Stuttgart (1982) pp. 23-30.
12. Persijn J. P., Korsten C. B. and Engelsman E.: Oestrogen and androgen receptors in breast cancer and response to endocrine therapy. Br. Med. J. 4 (1975) 503-509.
13. Allegra J. C., Lippman M. E., Thompson E. B., Simon R., Barlock A., Green L., Huff K. K., Do H. M. T., Aitken S. C. and Warren R.: Relationship between the progesterone, androgen, and glucocorticoid receptor and response rate to endocrine therapy in metastatic breast cancer. Cancer Res. 39 (1979) 1973-1979.
14. Langer M., Kubista E., Schemper M. and Spona J.: Androgen receptors, serum androgen levels and survival of breast cancer patients. Arch. Gynecol. Obstet. 247 (1990) 203-209.
15. Zwiorek L., Schmidt-Rhode P. and Schulz K.-D.: Androgen-receptors as a prognostic factor in breast cancer. Follow-up 1981-1991. J. Cancer Res. Clin. Oncol. 118S (1992) R112.
16. Prodi G., Nicoletti G., De Giovanni C., Galli M. C., Grilli S., Nanni P., Gola G., Rocchetta R. and Orlandi C.: Multiple steroid hormone receptors in normal and abnormal human endometrium. J. Cancer Res. Clin. Oncol. 98 (1980) 173-183.
17. CCNSC Breast Cancer Group: Testosterone propionate therapy in breast cancer. J. Am. Med. Assoc. 188 (1964) 1069-1070.
18. Goldenberg I. S., Waters M. N., Ravdin R. S., Ansfield F. J. and Segaloff A.: Androgenic therapy for advanced breast cancer in women. J. Am. Med. Assoc. 223 (1973) 1267-1268.
19. Hamblen E. C.: Androgen treatment of women. South Med. J. 50 (1957) 743-748.
20. Hackenberg R., Lüttchens S., Hofmann J., Kunzmann R., Hölzel F. and Schulz K.-D.: Androgen sensitivity of the new human breast cancer cell line MFM-223. Cancer Res. 51 (1991) 5722-5727.
21. Hackenberg R., Hawighorst Th., Filmer A., Slater E. P., Bock K., Beato M. and Schulz K.-D.: Regulation of androgen receptor mRNA and protein level by steroid hormones in human mammary cancer cells. J. Steroid Biochem. Molec. Biol. 43 (1992) 599-607.
22. Horwitz K. B., Costlow M. E. and McGuire W. L.: MCF-7: A human breast cancer cell line with estrogen, androgen, progesterone and glucocorticoid receptors. Steroids 26 (1975) 785-795.
23. Keydar I., Chen L., Karby S., Weiss F. R., Delarea J., Radu M., Chaitcik S. and Brenner H. J.: Establishment and characterization of a cell line of human breast carcinoma origin. Eur. J. Cancer 15 (1979) 659-670.
24. Engel L. W., Young N. A., Tralka T. S., Lippman M. E., O'Brien S. J. and Joyce M. J.: Establishment and characterization of three new continuous cell lines derived from human breast carcinomas. Cancer Res. 38 (1978) 3352-3364.
25. Hall R. E., Tilley W. D., McPhaul M. J. and Sutherland R. L.: Regulation of androgen receptor gene expression by steroids and retinoic acid in human breast-cancer cells. Int. J. Cancer 52 (1993) 778-784.
26. Hackenberg R., Beck S., Filmer A., Hushmand Nia A., Kunzmann R., Koch M., Slater E. P. and Schulz K.-D.: Androgen responsiveness of the new human endometrial cancer cell line MFE-296. Int. J. Cancer 57 (1994) 117-122.
27. Lippman M. E., Bolan G. and Huff K.: The effect of androgens and antiandrogens on hormone-responsive human breast cancer in long-term tissue culture. Cancer Res. 36 (1976) 4610-4618.
28. Hackenberg R., Hofmann J., Hölzel F. and Schulz K.-D.: Stimulatory effect of androgen and antiandrogen on the in vitro proliferation of human mammary carcinoma cells. J. Cancer Res. Clin. Oncol. 114 (1988) 593-601.
29. Chalbos D., Vignon F., Keydar I. and Rochefort H.: Estrogens stimulate cell proliferation and induce secretory proteins in a human breast cancer cell line (T47D). J. Clin. Endocr. Metab. 55 (1982) 276-283.
30. Poulin R., Baker D. and Labrie F.: Androgen inhibit basal and estrogen-induced proliferation in the ZR-75-1 human breast cancer cell line. Breast Cancer Res. Treat. 12 (1988) 213-225.
31. Zava D. T. and McGuire W. L.: Androgen action through estrogen receptor in a human breast cancer cell line. Endocrinology 103 (1978) 624-631.
32. Adams J., Garcia M. and Rochefort H.: Estrogenic effects of physiological concentrations of 5-androstene-3β-17β-diol and its metabolism in MCF-7 human breast cancer cells. Cancer Res. 41 (1981) 4720-4726.
33. Seymour-Mann K. and Adams J. B.: Estrogenic effects of 5-androstene-3β,17β-diol at physiological concentrations and its possible implication in the etiology of breast cancer. Endocrinology 112 (1983) 486-491.
34. Poulin R. and Labrie F.: Stimulation of cell proliferation and estrogenic response by adrenal C19-5-steroids in the ZR-75-1 human breast cancer cell line. Cancer Res. 46 (1986) 4933-4937.
35. Boccuzzi G., Brignardello E., DiMonaco M., Forte C., Leonardi L. and Pizzini A.: Influence of dehydroepiandrosterone and 5-ene-androstene-3β,17β-diol on the growth of MCF-7 human breast cancer cells induced by 17β-estradiol. Anticancer Res. 12 (1992) 799-804.
36. Träger L.: Steroidhormone. Springer, Berlin (1977) pp. 134-140.
37. Hackenberg R., Turgetto I., Filmer A. and Schulz K.-D.: Estrogen- and androgen receptor mediated stimulation and inhibition of proliferation by androst-5-ene-3β,17β-diol in human mammary cancer cells. J. Steroid Biochem. Molec. Biol. 46 (1993) 597-603.
38. Vignon F., Bardon S., Chalbos D. and Rochefort H.: Antiestrogenic effect or R5020, a synthetic progestin in human breast cancer cells in culture. J. Clin. Endocr. Metab. 56 (1983) 1124-1130.
39. Sutherland R. L., Hall R. E., Pang G. Y. N., Musgrove E. A. and Clarke C. L.: Effect of medroxyprogesterone acetate on proliferation and cell cycle kinetics of human mammary carcinoma cells. Cancer Res. 48 (1988) 5084-5091.
40. Hackenberg R., Hofmann J., Wolff G., Hölzel F. and Schulz K.-D.: Down-regulation of androgen receptor by progestins and interference with estrogenic or androgenic stimulation of mammary cancer cell growth. J. Cancer Res. Clin. Oncol. 116 (1990) 492-498.
41. Poulin R., Dufour J. M. and Labrie F.: Progestin inhibition of estrogen-dependent proliferation in ZR-75-1 human breast cancer cell: antagonism by insulin. Breast Cancer Res. Treat. 13 (1989) 265-276.
42. Hackenberg R., Hawighorst Th., Filmer A., Hushmand Nia A. and Schulz K.-D.: Medroxyprogesterone acetate inhibits the proliferation of estrogen- and progesterone-receptor negative MFM-223 human mammary cancer cells via the androgen receptor. Breast Cancer Res. Treat. 25 (1993) 217-224.
43. Blossey H. C., Wander H. E., Köbberling J. and Nagel G. A.: Pharmakokinetic and pharmakodynamic basis for the treatment of metastatic breast cancer with high-dose medroxyprogesterone acetate. Cancer 54 (1984) 1208-1215.
44. Becher R., Miller A. A., Höffken K., Gerhold U., Hirche H. and Schmidt C. G.: High-dose medroxyprogesterone-acetate in advanced breast cancer. Clinical and pharmakokinetic study with a combined oral and intramuscular regimen. Cancer 63 (1989) 1938-1943.
45. Stover E. P., Krishnan A. V. and Feldman D.: Estrogen down-regulation of androgen receptors in cultured human mammary cancer cells (MCF-7). Endocrinology 120 (1987) 2597-2603.
46. Baarends W. M., Themmen A. P. N., Blok L. J., Mackenbach P., Brinkmann A. O., Meijer D., Faber P. W., Trapman J. and Grootegoed J. A.: The rat androgen receptor gene promoter. Molec. Cell Endocr. 74 (1990) 75-84.
47. Klock G., Strähle U. and Schütz G.: Oestrogen and glucocorticoid responsive elements are closely related but distinct. Nature 329 (1987) 734-736.
48. Read L. D., Snider C. E., Miller J. S., Greene G. L. and Katzenellenbogen B. S.: Ligand-modulated regulation of progesterone receptor messenger ribonucleic acid and protein in human breast cancer cell lines. Molec. Endocr. 2 (1988) 263-271.
49. Read L. D., Greene G. L. and Katzenellenbogen B. S.: Regulation of estrogen receptor messenger ribonucleid acid and protein levels in human breast cancer cell lines by sex steroid hormones, their antagonists, and growth factors. Molec. Endocr. 3 (1989) 295-304.
50. Saceda M., Lippman M. E., Lindsey R. K., Puente M. and Martin M. B.: Role of an estrogen receptor-dependent mechanism in the regulation of estrogen receptor mRNA in MCF-7 cells. Molec. Endocr. 3 (1989) 1782-1787.
51. Haagensen D. E.: Is cystic disease related to breast cancer? Am. J. Surg. Pathol. 15 (1991) 687-694.
52. Chalbos D., Haagensen D. E., Parish T. and Rochefort H.: Identification and androgen regulation of two proteins released by T47D human breast cancer cells. Cancer Res. 47 (1987) 2787-2792.
53. Simard J., Dauvois S., Haagensen D. E., Lévesque C., Mérand Y. and Labrie F.: Regulation of progesterone-binding breast cyst protein GCDFP-24 secretion by estrogens and androgens in human breast cancer cells: a new marker of steroid action in breast cancer. Endocrinology 126 (1990) 3223-3231.
54. Haagensen D. E., Stewart P., Dilley W. G. and Wells S. A.: Secretion of breast gross cystic disease fluid proteins by T47D breast cancer cells in culture-modulation by steroid hormones. Breast Cancer Res. Treat. 23 (1992) 77-86.
55. Bradlow H. L., Rosenfeld R. S., Kream J., Fleisher M., O'Conner J. and Schwartz M.: Steroid hormone accumulation in human breast cyst fluid. Cancer Res. 41 (1981) 105-111.
56. Mazoujian G. and Haagensen D. E.: The immunopathological gross cyst disease fluid proteins. Workshop on biochemistry of breast cyst fluid and cancer risk. Ann. NY Acad. Sci. 586 (1990) 188-191.